Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial ResultsPRNewsWire • 04/23/26
Conestoga Capital Small Cap Portfolio Quarterly Scorecard: Buys, Sells, And StandoutsSeeking Alpha • 04/23/26
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferencePRNewsWire • 03/03/26
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual MeetingPRNewsWire • 02/02/26
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial ResultsPRNewsWire • 01/29/26
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal TrialPRNewsWire • 11/06/25
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial ResultsPRNewsWire • 10/23/25
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual MeetingPRNewsWire • 10/13/25
Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/10/25
Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare ConferencePRNewsWire • 09/05/25
Share Growth And Strong Clinical Results Continue To Support The Artivion StorySeeking Alpha • 09/03/25